Marshall Wace
BIVI icon

Marshall Wace’s BioVie BIVI Stock Holding History

Marshall Wace’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-162
Closed -$131K – 2480
2023
Q1 		$131K Buy
+162
New +$107K ﹤0.01% 2465

Other funds holding BIVI

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace's BIVI Position: Q2 2023 in Review

Marshall Wace sold out of BioVie (BIVI) in Q2 2023, closing a stake of 162 shares — an estimated $131K sold.

Marshall Wace first reported a position in BIVI in Q1 2023 and held it in 1 quarter. The position peaked at $131K in Q1 2023. 53 funds tracked by Wall St. Rank hold BIVI as of Q2 2023.

  • Marshall Wace reported no remaining BioVie position as of Q2 2023 after selling out during the quarter.
  • Marshall Wace sold 162 BioVie shares in Q2 2023, an estimated $131K.
  • Marshall Wace first reported a position in BioVie in Q1 2023 and held it in 1 quarter.
  • Marshall Wace's BioVie position peaked at $131K in Q1 2023.
  • 53 funds tracked by Wall St. Rank held BioVie as of Q2 2023.

Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.